Boston Scientific Corp
BSX- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000885725
In the last 90 days, Boston Scientific Corp insiders filed 1 open-market purchase and 0 sales; 1,492 institutions reported holding it in 13F filings for Q2 2026, worth $57.3B in total; Maverick Capital is the only superinvestor holding it.
Key figures
- Market capClose on Nov 11, 2026
- $65.4B
- Insider buysLast 90 days, $100.4K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −178 vs. previous quarter
- 1,492
- 13F valueReported value at the end of Q2 2026
- $57.3B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $20.1B
- +19.9% year over year
- Net income, FY2025
- $2.89B
- +56.7% year over year
- Free cash flow, FY2025
- $3.66B
- +38.3% year over year
- Revenue, Q3 FY2026
- $5.14B
- +1.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 35.1M
- Shares sold short
- Change
- −5.59M
- −13.7% vs. previous
- Days to cover
- 1.65
- At average daily volume
Superinvestors holding BSX, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Boston Scientific Corp on Form 13F. Percentages are the stock's share of each portfolio.
Maverick Capital
Lee Ainslie
2.3%
Boston Scientific Corp's share of the portfolio
- Shares
- 5,937,553
- Value
- $253.4M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Boston Scientific Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 (view filing)6:46 PM ET | Aug 25 | 1 day | Morano Susan EDirector | PPurchase | +2.04K | $49.22 | +$100.4K | +17.4%13.8K after | |
| Aug 7, 2026 (view filing)4:16 PM ET | Aug 5 | 2 days | Habiger David CDirector | PPurchase | +2.10K | $47.59 | +$99.9K | +13.9%17.2K after | |
| Aug 5, 2026 (view filing)4:15 PM ET | Aug 3-4 | 2 days | Habiger David CDirector | PPurchase | +1.18K | $48.13 | +$56.9K | +8.5%15.1K after | 2 lots |
| Aug 5, 2026 (view filing)4:15 PM ET | Aug 3 | 2 days | Mahoney Michael FChairman, President & CEO | PPurchase | +186.2K | $48.33 | +$9.00M | +13.3%1.59M after | |
| Aug 3, 2026 (view filing)4:29 PM ET | Jul 31 | 3 days | Ludwig Edward JDirector | PPurchase | +5.00K | $45.48 | +$227.4K | +19.7%30.4K after | |
| May 21, 2026 (view filing) | May 20 | 1 day | Pegus CherylDirector | PPurchase | +1.77K | $56.49 | +$100.0K | New position1.77K after | |
| May 21, 2026 (view filing) | May 20 | 1 day | Ludwig Edward JDirector | PPurchase | +3.58K | $56.68 | +$202.9K | +16.4%25.4K after | |
| May 21, 2026 (view filing) | May 19-20 | 2 days | Habiger David CDirector | PPurchase | +4.45K | $56.43 | +$251.1K | +47.2%13.9K after | 2 lots |
| Feb 3, 2026 (view filing) | Feb 2 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −160.9K | $93.49 | −$15.0M | −10.2%1.41M after | 2 lots10b5-1 |
| Dec 2, 2025 (view filing) | Dec 1 | 1 day | Butcher Arthur CEVP& Grp Pres, MedSurg & APAC | SSale | −17.3K | $101.55 | −$1.76M | −42.3%23.6K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 1,492 holdersThe largest institutional positions in Boston Scientific Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 129,680,916 | $5.53B | 0.08% | −2,141,121−1.6% | Reduced |
| Vanguard Capital Management LLC | 97,087,553 | $4.14B | 0.09% | +675,985+0.7% | Added |
| State Street Corp | 70,111,196 | $2.99B | 0.09% | +2,124,349+3.1% | Added |
| Primecap Management Co | 50,520,914 | $2.16B | 1.28% | +17,991,140+55.3% | Added |
| FMR LLC | 45,702,845 | $1.95B | 0.08% | −28,523,550−38.4% | Reduced |
| Massachusetts Financial Services Co | 24,859,191 | $1.50B | 0.48% | +13,862,619+126.1% | Added |
| Geode Capital Management, LLC | 33,440,102 | $1.42B | 0.08% | +154,345+0.5% | Added |
| Vanguard Portfolio Management LLC | 29,792,794 | $1.27B | 0.06% | −3,4170.0% | Reduced |
| D. E. Shaw & Co., Inc. | 25,457,409 | $1.09B | 0.67% | +1,145,057+4.7% | Added |
| JPMorgan Chase & Co | 23,907,838 | $1.04B | 0.06% | −9,442,319−28.3% | Reduced |
Holders of 5% or more of BSX
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Boston Scientific Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.60%113.0M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 7.47%111.1M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Politician trades
All politician trades in BSX17 members of Congress reported 91 trades in Boston Scientific Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 25, 2026 |  Kevin Hern House · OK | Sell (partial) | $50K-$100K |
| Sep 25, 2026 | Kevin Hern House · OK | Sell | $1K-$15K |
| Sep 25, 2026 | Kevin Hern House · OK | Sell | $1K-$15K |
| Sep 25, 2026 | Kevin Hern House · OK | Sell | $1K-$15K |
| Sep 25, 2026 | Kevin Hern House · OK | Sell | $50K-$100K |
House · OK · Sep 25, 2026
Sell (partial)$50K-$100K
House · OK · Sep 25, 2026
Sell$1K-$15K
House · OK · Sep 25, 2026
Sell$1K-$15K
House · OK · Sep 25, 2026
Sell$1K-$15K
House · OK · Sep 25, 2026
Sell$50K-$100K